Hospital de Cancer de Barretos - Fundacao Pio XII Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01859728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hospital do Cancer de Barretos - Fundação PIO XII | Hospital do Cancer de Barretos Fundacao Pio XII

Active Ingredients

Drugs in Phase 3 Trials (1)

tanezumab (1 trial)

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

gemcitabine (gemzar) (1 trial)

irinotecan (Camptosar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Biliary Tract Neoplasms (Phase 2)

Cancer Pain (Phase 3)

Musculoskeletal Pain (Phase 3)

Neoplasm Metastasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4